666 related articles for article (PubMed ID: 26762412)
1. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.
Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A
Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
3. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
[TBL] [Abstract][Full Text] [Related]
4. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
[TBL] [Abstract][Full Text] [Related]
5. Cadherin-12 contributes to tumorigenicity in colorectal cancer by promoting migration, invasion, adhersion and angiogenesis.
Zhao J; Li P; Feng H; Wang P; Zong Y; Ma J; Zhang Z; Chen X; Zheng M; Zhu Z; Lu A
J Transl Med; 2013 Nov; 11():288. PubMed ID: 24237488
[TBL] [Abstract][Full Text] [Related]
6. miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
Cui F; Wang S; Lao I; Zhou C; Kong H; Bayaxi N; Li J; Chen Q; Zhu T; Zhu H
Oncol Rep; 2016 Jul; 36(1):487-93. PubMed ID: 27222350
[TBL] [Abstract][Full Text] [Related]
7. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
Xin H; Wang C; Liu Z
BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
[TBL] [Abstract][Full Text] [Related]
8. MLLT10 promotes tumor migration, invasion, and metastasis in human colorectal cancer.
Jing X; Wu H; Cheng X; Chen X; Zhang Y; Shi M; Zhang T; Wang X; Zhao R
Scand J Gastroenterol; 2018 Aug; 53(8):964-971. PubMed ID: 30102091
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
[TBL] [Abstract][Full Text] [Related]
11. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
12. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
13. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
[TBL] [Abstract][Full Text] [Related]
14. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
15. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
17. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
[TBL] [Abstract][Full Text] [Related]
18. JianPi JieDu Recipe Inhibits Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF-
Liu X; Ji Q; Deng W; Chai N; Feng Y; Zhou L; Sui H; Li C; Sun X; Li Q
Biomed Res Int; 2017; 2017():2613198. PubMed ID: 28299321
[TBL] [Abstract][Full Text] [Related]
19. Increased EWSAT1 expression promotes cell proliferation, invasion and epithelial-mesenchymal transition in colorectal cancer.
Zhang R; Li JB; Yan XF; Jin K; Li WY; Xu J; Zhao J; Bai JH; Chen YZ
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6801-6808. PubMed ID: 30402843
[TBL] [Abstract][Full Text] [Related]
20. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]